Literature DB >> 2009056

Local-regional breast cancer recurrence following mastectomy.

J P Crowe1, N H Gordon, A R Antunez, R R Shenk, C A Hubay, J M Shuck.   

Abstract

Local-regional recurrence patterns were investigated in 1392 patients with breast cancer. Primary treatment for all patients included a mastectomy. Nine hundred seventeen patients had negative nodes and did not receive systemic therapy. Four hundred seventy-five patients had node metastases and were randomized to receive different combinations of chemoendocrine therapy. Follow-up ranged between 5 and 16 years. Two hundred thirty (25.8%) node-negative patients have had recurrences, with the initial recurrence being local-regional in 9.2%. Two hundred forty-two (50.9%) node-positive patients have had recurrences, with the initial recurrence being local-regional in 17.1%. Larger tumors and more extensive node involvement were associated with more first local-regional recurrences. The relative percent of first local-regional recurrence among patients in whom cancer recurred was similar for node-negative and node-positive patients (35.4% and 33.5%, respectively). In 63.6% of patients in whom cancer recurred, first local-regional recurrence were distant. Larger tumors, more extensive node involvement, and a shorter disease-free interval after mastectomy were associated with more rapid appearance of distant recurrence among these patients.

Entities:  

Mesh:

Year:  1991        PMID: 2009056     DOI: 10.1001/archsurg.1991.01410280027002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Authors:  Jonathan Karnon; Jackie Brown
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer.

Authors:  Heriberto Medina-Franco; Luis O Vasconez; R Jobe Fix; Martin J Heslin; Samuel W Beenken; Kirby I Bland; Marshall M Urist
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.

Authors:  A Rocchi; S Verma
Journal:  Support Care Cancer       Date:  2006-04-05       Impact factor: 3.603

4.  Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients.

Authors:  E M Mora; S E Singletary; A U Buzdar; D A Johnston
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

5.  Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Authors:  Siyu Wu; Miao Mo; Yujie Wang; Na Zhang; Jianwei Li; Genhong Di; Zhimin Shao; Jiong Wu; Guangyu Liu
Journal:  Onco Targets Ther       Date:  2016-11-04       Impact factor: 4.147

6.  Investigation of Prognostic Factors and Survival without Recurrence in Patients with Breast Cancer.

Authors:  Ahmad Abdollahi; Hamzeh Saleh Zadeh; Mojtaba Akbari; Sedigheh Tahmasbi; Abdolrasoul Talei; Jafar Hassanzadeh
Journal:  Adv Biomed Res       Date:  2017-04-17

7.  Oncologic safety of skin-sparing and nipple-sparing mastectomy: a discussion and review of the literature.

Authors:  Christopher Tokin; Anna Weiss; Jessica Wang-Rodriguez; Sarah L Blair
Journal:  Int J Surg Oncol       Date:  2012-07-17

8.  Recurrence after skin-sparing mastectomy and immediate transverse rectus abdominis musculocutaneous flap reconstruction for invasive breast cancer.

Authors:  Tsung-Jung Liang; Being-Whey Wang; Shiuh-Inn Liu; Ming-Hsin Yeh; Yu-Chia Chen; Jin-Shyr Chen; King-Tong Mok; Hong-Tai Chang
Journal:  World J Surg Oncol       Date:  2013-08-14       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.